Last update May 11, 2019
An antibacterial oxazolidinone, indicated in the treatment of skin, soft tissue and lung infections by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin.
Oral or intravenous administration every 12 hours.
Its use is authorized in small infants and neonates.
It is excreted in breastmilk in moderate amounts which could be significant (Lim 2017, Rowe 2014, Sagirli 2009), but it is less than one tenth of the dose used in neonates and infants.
Possible side effects are not serious or frequent.
Several experts believe that the use of this medication is probably compatible during breastfeeding (Briggs 2017, Hale 2017 p563).
Be aware of false negative results of bacterial cultures obtained from febrile infants whose mothers are on antibiotics, as well as the possibility of gastroenteritis due to altered intestinal flora (Briggs 2017, Ito 1993).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.